PROTAC EZH2 Degrader-2
PROTAC EZH2 Degrader-2 is a PROTAC EZH2 inhibitor. PROTAC EZH2 Degrader-2 degrades EZH2 in SU-DHL-6 cells in a dose-dependent manner. PROTAC EZH2 Degrader-2 induces apoptosis and reduces mitochondrial membrane potential in SU-DHL-6 cells. PROTAC EZH2 Degrader-2 has anti-cancer and anti-proliferative activity. (Pink: EZH2 ligand , Blue: MDM2 Ligand (HY-147230), Black: Linker (HY-175707), EZH2 ligand-linker conjugate (HY-175706) ).
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Histone Methyltransferase; PROTACs
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/protac-ezh2-degrader-2.html
Purity
99.78
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C77H93Cl2N13O12
Molecular Weight
1463.55
References & Citations
[1]Xie H et al. Design, synthesis and evaluation of EZH2-based PROTACs targeting PRC2 complex in lymphoma. Bioorg Chem. 2023 Nov;140:106762.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EZH2; MDM2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD21 (CD21 Antigen, Complement Component (3d/Epstein Barr Virus) Receptor 2, Complement Receptor 2, Complement Receptor Type 2 Precursor, CR2, Complement C3d Receptor, C3DR, Epstein-Barr Virus Receptor, EBV Receptor, SLEB9) (HRP)